111
Views
34
CrossRef citations to date
0
Altmetric
Original Research

Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis

, , , , , , , , , , , , , , & show all
Pages 789-801 | Published online: 17 Jan 2019

References

  • KesariSBatchelorTTLeptomeningeal metastasesNeurol Clin2003211256612690644
  • KaplanJGDesouzaTGFarkashALeptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemiasJ Neurooncol1990932252292086737
  • Le RhunEWellerMBrandsmaDEANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumoursAnn Oncol201728Suppl 4iv84iv9928881917
  • ClarkeJLPerezHRJacksLMPanageasKSDeangelisLMLeptomeningeal metastases in the MRI eraNeurology201074181449145420439847
  • UmemuraSTsubouchiKYoshiokaHClinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study GroupLung Cancer201277113413922487432
  • MorrisPGReinerASSzenbergORLeptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapyJ Thorac Oncol20127238238522089116
  • Lara-MedinaFCrismattAVillarreal-GarzaCClinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancerBreast J201218323324122487060
  • NugentJLBunnPAMatthewsMJCNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survivalCancer197944518851893227582
  • YapHYYapBSTashimaCKDistefanoABlumenscheinGRMeningeal carcinomatosis in breast cancerCancer1978421283286667799
  • WasserstromWRGlassJPPosnerJBDiagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patientsCancer19824947597726895713
  • GrossmanSAKrabakMJLeptomeningeal carcinomatosisCancer Treat Rev199925210311910395835
  • Le RhunETaillibertSZairiFA retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancerJ Neurooncol20131131839223456656
  • LeeSJLeeJINamDHLeptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factorsJ Thorac Oncol20138218519123328548
  • BrowerJVSahaSRosenbergSAHullettCRIan RobinsHManagement of leptomeningeal metastases: prognostic factors and associated outcomesJ Clin Neurosci20162713013726778048
  • OzdemirYYildirimBATopkanEWhole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomen-ingeal carcinomatosis: evaluation of prognostic factorsJ Neurooncol2016129232933527306442
  • GwakHSJooJKimSAnalysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancerJ Thorac Oncol20138559960523422833
  • GrossmanSAFinkelsteinDMRuckdeschelJCTrumpDLMoynihanTEttingerDSRandomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology GroupJ Clin Oncol19931135615698445432
  • HitchinsRNBellDRWoodsRLLeviJAA prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosisJ Clin Oncol1987510165516623309199
  • GlantzMJJaeckleKAChamberlainMCA randomized controlled trial comparing intrathecal sustained-release cytarabine (Depo-Cyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumorsClin Cancer Res19995113394340210589750
  • KwonJChieEKKimKImpact of multimodality approach for patients with leptomeningeal metastases from solid tumorsJ Korean Med Sci2014298109425120319
  • BernierVTechnical aspects in cerebrospinal irradiationPediatr Blood Cancer200442544745115049018
  • SchiopuSRHablGHäfnerMCraniospinal irradiation using helical tomotherapy for central nervous system tumorsJ Radiat Res201758223824628096196
  • TsangDSMurphyESEzellSELucasJTTinkleCMerchantTECraniospinal irradiation for treatment of metastatic pediatric low-grade gliomaJ Neurooncol2017134231732428623604
  • HermannBHültenschmidtBSautter-BihlMLRadiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosisStrahlenther Onkol2001177419519911370554
  • KumarNMiriyalaRThakurPImpact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experienceJ Neurooncol2017134230931528577033
  • Zong-WenSShuang-YanYFeng-LeiDRadiotherapy for adult medulloblastoma: evaluation of helical tomotherapy, volumetric intensity modulated arc therapy, and three-dimensional conformal radiotherapy and the results of helical tomotherapy therapyBiomed Res Int2018201818
  • WangKMengHChenJZhangWFengYPlan quality and robustness in field junction region for craniospinal irradiation with VMATPhys Med201848212629728225
  • SeravalliEBosmanMLassen-RamshadYDosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group)Acta Oncol20185791240124929698060
  • FaracePBizzocchiNRighettoRSupine craniospinal irradiation in pediatric patients by proton pencil beam scanningRadiother Oncol2017123111211828283192
  • BezjakAAdamJBartonRSymptom response after palliative radiotherapy for patients with brain metastasesEur J Cancer200238448749611872340
  • National Institutes of Health NCICommon Terminology Criteria for Adverse Events v4.0 (CTCAE) Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdfhttp://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf Published 2010Accessed December 19, 2016
  • RiefHBischofMBrucknerTThe stability of osseous metastases of the spine in lung cancer – a retrospective analysis of 338 casesRadiat Oncol20138120023937907
  • ScharpMHauswaldHBischofMDebusJCombsSERe-irradiation in the treatment of patients with cerebral metastases of solid tumors: retrospective analysisRadiat Oncol201491424387239
  • SchemperMSmithTLA note on quantifying follow-up in studies of failure timeControl Clin Trials19961743433468889347
  • BowerMWaxmanJCentral nervous system cancersLecture Notes OncologyPA, USANational Comprehensive Cancer Network V220189697
  • SandbergDIBilskyMHSouweidaneMMBzdilJGutinPHOmmaya reservoirs for the treatment of leptomeningeal metastasesNeurosurgery2000471495410917346
  • GrovesMDGlantzMJChamberlainMCA multicenter Phase II trial of intrathecal topotecan in patients with meningeal malignanciesNeuro Oncol200810220821518316473
  • ChamberlainMCTsao-WeiDDGroshenSPhase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitisCancer200610692021202716583432
  • ZagouriFSergentanisTNBartschRIntrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysisBreast Cancer Res Treat20131391132223588955
  • BaumanGYartsevSCoadTFisherBKronTHelical tomotherapy for craniospinal radiationBr J Radiol20057893054855215900062
  • SterzingFSchubertKSroka-PerezGKalzJDebusJHerfarthKHelical tomotherapyStrahlenther Onkol2008184181418188517
  • SharmaDSGuptaTJalaliRMasterZPhurailatpamRDSarinRHigh-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapyBr J Radiol2009829841000100919581313
  • HongJYKimGWKimCUSupine linac treatment versus tomotherapy in craniospinal irradiation: planning comparison and dosimetric evaluationRadiat Prot Dosimetry20111461–336436621515620
  • KunosCADobbinsDCKulasekereRLatimerBKinsellaTJComparison of helical tomotherapy versus conventional radiation to deliver craniospinal radiationTechnol Cancer Res Treat20087322723318473494
  • SugieCShibamotoYAyakawaSCraniospinal irradiation using helical tomotherapy: evaluation of acute toxicity and dose distributionTechnol Cancer Res Treat201110218719521381797
  • PeñagarícanoJMorosECorryPSaylorsRRatanatharathornVPediatric craniospinal axis irradiation with helical tomotherapy: patient outcome and lack of acute pulmonary toxicityInt J Radiat Oncol Biol Phys20097541155116119467796
  • PeterssonKGebre-MedhinMCebergCHaematological toxicity in adult patients receiving craniospinal irradiation – indication of a dose-bath effectRadiother Oncol20141111475124680378
  • MyersPAMavroidisPPapanikolaouNStathakisSComparing conformal, arc radiotherapy and helical tomotherapy in craniospinal irradiation planningJ Appl Clin Med Phys20141551228
  • MascarinMGiuglianoFMCoassinEHelical tomotherapy in children and adolescents: dosimetric comparisons, opportunities and issuesCancers2011343972399024213120
  • HansenATLukacovaSLassen-RamshadYPetersenJBComparison of a new noncoplanar intensity-modulated radiation therapy technique for craniospinal irradiation with 3 coplanar techniquesMed Dosim201540429630326002123
  • SarkarBMunshiAManikandanAA low gradient junction technique of craniospinal irradiation using volumetric-modulated arc therapy and its advantages over the conventional therapyCancer Radiother2018221627229195796
  • MacewanIChouBMoretzJLoredoLBushDSlaterJDEffects of vertebral-body-sparing proton craniospinal irradiation on the spine of young pediatric patients with medulloblastomaAdv Radiat Oncol20172222022728740935
  • GiantsoudiDSecoJEatonBREvaluating intensity modulated proton therapy relative to passive scattering proton therapy for increased vertebral column sparing in craniospinal irradiation in growing pediatric patientsInt J Radiat Oncol Biol Phys2017981374628587051
  • YockTIYeapBYEbbDHLong-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a Phase 2 single-arm studyLancet Oncol201617328729826830377
  • FaracePVinanteLRavanelliDBizzocchiNVennariniSPlanning field-junction in proton cranio-spinal irradiation – the ancillary-beam techniqueActa Oncol20155471075107825350525
  • KakMNandaRRamsdaleEELukasRVTreatment of leptomeningeal carcinomatosis: current challenges and future opportunitiesJ Clin Neurosci201522463263725677875
  • GauthierHGuilhaumeMNBidardFCSurvival of breast cancer patients with meningeal carcinomatosisAnn Oncol201021112183218720430906
  • RudnickaHNiwińskaAMurawskaMBreast cancer leptomeningeal metastasis – the role of multimodality treatmentJ Neurooncol2007841576217310266
  • BoogerdWHartAAvan der SandeJJEngelsmanEMeningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatmentCancer1991676168516952001559
  • MorrisZWhiteleyWNLongstrethWTIncidental findings on brain magnetic resonance imaging: systematic review and meta-analysisBMJ2009339b301619687093
  • GaniCMüllerACEckertFOutcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumorsStrahlenther Onkol2012188214815322231633
  • de AzevedoCRCruzMRChinenLTMeningeal carcinomatosis in breast cancer: prognostic factors and outcomeJ Neurooncol2011104256557221234642
  • BernhardtDBozorgmehrFAdebergSOutcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiationLung Cancer2016101768127794411
  • GasparLScottCRotmanMRecursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trialsInt J Radiat Oncol Biol Phys19973747457519128946
  • SperdutoPWBerkeyBGasparLEMehtaMCurranWA new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG databaseInt J Radiat Oncol Biol Phys200870251051417931798
  • SperdutoPWKasedNRobergeDSummary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastasesJ Clin Oncol201230441942522203767
  • GrommesCOxnardGRKrisMG“Pulsatile” high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancerNeuro Oncol201113121364136921865399
  • GossGTsaiCMShepherdFACNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two Phase II trialsAnn Oncol201829368769329293889